PO.ET08.03 · 实验与分子治疗

一种用于准确检测体细胞突变的通用双链测序方法

A universal duplex sequencing approach for accurate detection of somatic mutations

海报缩略图:一种用于准确检测体细胞突变的通用双链测序方法
编号 7205 展板 24 时间 4/22 09:00–12:00 区域 Section 17 主讲 Shuvro Prokash Nandi, BS;MS;PhD
分会场 Targeted Radiopharmaceuticals and Combination Strategies in Cancer Therapy
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Shuvro Prokash Nandi1, Yuhe Cheng2, Shams Al-azzam3, Safa Saeed2, Isabella R Stuewe1, Zichen Jiang2, Luka Culibrk4, Maria Zhivagui5, Xiaoxu Yang6, Rachel M. Wise7, Foster C. Jacobs8, Bérénice Chavanel9, Michael Korenjak9, Mia PETLJAK10, Silvia Balbo11, Laurie G. Hudson12, Ke Jian Liu13, Jiri Zavadil9, Joseph G. Gleeson14, Ludmil B. Alexandrov3

1Cellular and Molecular Medicine, UCSD Moores Cancer Center, La Jolla, CA,2UCSD, La Jolla, CA,3UC San Diego Health, San Diego, CA,4Department of Pathology, Grossman Medical School, New York, NY,5University of Nevada, Las Vegas (UNLV), Las Vegas, NV,6Department of Human Genetics, University of Utah, Salt Lake City, UT,7Department of Pharmaceutical Sciences, University of New Mexico, Albuquerque, NM,8University of Minnesota, Minneapolis, MN,9International Agency for Research on Cancer WHO, Lyon, France,10NYU Langone Health, New York, NY,11Postdoctoral Fellow, Masonic Cancer Ctr., University of Minnesota Masonic Cancer Center, Minneapolis, MN,12Professor, Dept. of Pharmaceutical Sci., Univ. of New Mexico Health Sciences Ctr., Albuquerque, NM,13Stony Brook Cancer Center, Stony Brook, NY,14Rady Children’s Institute for Genomic Medicine, San Diego, CA

摘要 Abstract

中文摘要
体细胞突变源于内源性和外源性诱变过程,随时间累积并促成衰老和疾病。由于现有测序方法的高错误率、有限的基因组覆盖度和大量的DNA输入需求,在非克隆组织中检测这些罕见突变仍是一项重大挑战。在此,我们介绍UDSeq,一种高准确度、经济高效的单分子双链测序方案,旨在克服这些限制。我们将UDSeq置于现有双链测序方法的背景下,证明它实现了每碱基对约2.5 × 10⁻⁹的极低错误率,支持从低至100皮克的DNA进行全基因组和靶向捕获测序,并从相同的输入中提供比当前最先进方法多达四倍的可用双链分子。我们通过一系列体外和体内诱变实验证明了UDSeq的广泛适用性,准确捕获了环境致癌物在人类细胞系、啮齿动物和非模式生物中诱导的已知突变特征。我们进一步将UDSeq应用于一名70岁个体的正常组织,揭示了器官特异性的突变负荷和不同突变过程的活性。凭借其高准确度、低输入需求和广泛适用性,UDSeq提供了一种强大且可扩展的工具,用于研究不同生物学背景下的突变过程。其多功能性支持在癌症研究、衰老和环境暴露方面的应用,扩展了我们在健康和患病组织中表征体细胞突变的能力。
查看英文原文 English abstract
Somatic mutations arise from endogenous and exogenous mutagenic processes, accumulating over time and contributing to aging and disease. Detecting these rare mutations in non-clonal tissues remains a significant challenge due to the high error rates, limited genome coverage, and substantial DNA input requirements of existing sequencing approaches. Here, we introduce UDSeq, a high-accuracy, cost-effective, single-molecule duplex sequencing protocol designed to overcome these limitations. We place UDSeq in the context of existing duplex sequencing approaches, demonstrating that it achieves an exceptionally low error rate of ~2.5 × 10 -9 per base pair, supports whole-genome and targeted capture sequencing from as little as 100 picograms of DNA, and delivers up to four times more usable duplex molecules than current state-of-the-art methods from the same input. We demonstrated the broad applicability of UDSeq through a series of in vitro and in vivo mutagenesis experiments, accurately capturing known mutational signatures induced by environmental carcinogens in human cell lines, rodents, and non-model organisms. We further applied UDSeq to normal tissues from a 70-year-old individual, revealing organ-specific mutational burdens and the activity of distinct mutational processes. With its high accuracy, low input requirements, and wide applicability, UDSeq provides a powerful and scalable tool for studying mutational processes across diverse biological contexts. Its versatility supports applications in cancer research, aging, and environmental exposure, expanding our capacity to characterize somatic mutations in both healthy and diseased tissues.
利益披露 Disclosure
S. Nandi, None.. S. Saeed, None.. I. Stuewe, None.. L. Culibrk, None.. X. Yang, None.. R. Wise, None.. F. Jacobs, None.. B. Chavanel, None.. M. Korenjak, None.. K. Liu, None.. J. Zavadil, None.. J. Gleeson, None.

← 返回 AACR 2026 检索